NWP-103

N/A

Report date: 2024/10/11 13:39:16

Base Information

Drug NameNWP-103
Drug Alias NameNWP-103
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukodystrophy, Globoid Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNEUWAY Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesNEUWAY Pharma GmbH
Inactive CompaniesN/A
Active IndicationsLeukodystrophy, Globoid Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A